Found: 75
Select item for more details and to access through your institution.
Nigrostriatal tau pathology in parkinsonism and Parkinson's disease.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 2, p. 444, doi. 10.1093/brain/awad388
- By:
- Publication type:
- Article
Plasma metabolomics indexes time to clinical dementia in autosomal dominant Alzheimer's disease mutation carriers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.066973
- By:
- Publication type:
- Article
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer's disease.
- Published in:
- GeroScience, 2022, v. 44, n. 3, p. 1525, doi. 10.1007/s11357-022-00580-w
- By:
- Publication type:
- Article
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6204, doi. 10.3390/cancers13246204
- By:
- Publication type:
- Article
Author Correction: Plasma microRNA markers of upper limb recovery following human stroke.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Effect of early-stage Alzheimer's disease on household financial outcomes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Fetal Bovine Serum-Derived Extracellular Vesicles Persist within Vesicle-Depleted Culture Media.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 11, p. 3538, doi. 10.3390/ijms19113538
- By:
- Publication type:
- Article
Potential Metabolomic Linkage in Blood between Parkinson's Disease and Traumatic Brain Injury.
- Published in:
- Metabolites (2218-1989), 2018, v. 8, n. 3, p. 50, doi. 10.3390/metabo8030050
- By:
- Publication type:
- Article
Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195318
- By:
- Publication type:
- Article
Systems healthcare: a holistic paradigm for tomorrow.
- Published in:
- BMC Systems Biology, 2017, v. 11, p. 1, doi. 10.1186/s12918-017-0521-2
- By:
- Publication type:
- Article
Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.
- Published in:
- Frontiers in Aging Neuroscience, 2017, p. 1, doi. 10.3389/fnagi.2017.00176
- By:
- Publication type:
- Article
Biomarker validation: Methods and matrix matter.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, n. 5, p. 608, doi. 10.1016/j.jalz.2016.11.004
- By:
- Publication type:
- Article
Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease.
- Published in:
- Frontiers in Neurology, 2015, v. 6, p. 1, doi. 10.3389/fneur.2015.00237
- By:
- Publication type:
- Article
PGC−1α Promoter Methylation in Parkinson’s Disease.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0134087
- By:
- Publication type:
- Article
Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 6, p. 600, doi. 10.1016/j.jalz.2014.06.008
- By:
- Publication type:
- Article
The critical need for defining preclinical biomarkers in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 3, p. S196, doi. 10.1016/j.jalz.2014.04.015
- By:
- Publication type:
- Article
The Evolution of Gene Transfer, Gene Therapy, and the RAC: IOM Recommendations to the NIH Director.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 4, p. 685, doi. 10.1038/mt.2014.37
- By:
- Publication type:
- Article
Plasma phospholipids identify antecedent memory impairment in older adults.
- Published in:
- Nature Medicine, 2014, v. 20, n. 4, p. 415, doi. 10.1038/nm.3466
- By:
- Publication type:
- Article
Immune Responses in Parkinson's Disease: Interplay between Central and Peripheral Immune Systems.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/275178
- By:
- Publication type:
- Article
Immune responses in Parkinson's disease: interplay between central and peripheral immune systems.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Single-Chain Fragment Variable Passive Immunotherapies for Neurodegenerative Diseases.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 9, p. 19109, doi. 10.3390/ijms140919109
- By:
- Publication type:
- Article
Ectodomain shedding of nectin-1 regulates the maintenance of dendritic spine density.
- Published in:
- Journal of Neurochemistry, 2012, v. 120, n. 5, p. 741, doi. 10.1111/j.1471-4159.2011.07592.x
- By:
- Publication type:
- Article
Characterization of nectin processing mediated by presenilin-dependent gamma-secretase.
- Published in:
- Journal of Neurochemistry, 2011, v. 119, n. 5, p. 945, doi. 10.1111/j.1471-4159.2011.07479.x
- By:
- Publication type:
- Article
Evaluation of an AAV2-Based Rapamycin-Regulated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Vector System.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027728
- By:
- Publication type:
- Article
Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional 'detour' in the hemisected spinal cord.
- Published in:
- European Journal of Neuroscience, 2011, v. 34, n. 8, p. 1256, doi. 10.1111/j.1460-9568.2011.07862.x
- By:
- Publication type:
- Article
Disclosure of Clinical Trial Results When Product Development Is Abandoned.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 102, p. 1, doi. 10.1126/scitranslmed.3002939
- By:
- Publication type:
- Article
Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 6, p. 1048, doi. 10.1038/mt.2011.11
- By:
- Publication type:
- Article
Multidisciplinary Approaches to Biomedical Research.
- Published in:
- 2010
- By:
- Publication type:
- Letter
PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 52, p. 1, doi. 10.1126/scitranslmed.3001059
- By:
- Publication type:
- Article
A New Research and Development Policy Framework for the Biomedical Research Enterprise.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.
- Published in:
- Nature Medicine, 2010, v. 16, n. 9, p. 998, doi. 10.1038/nm.2199
- By:
- Publication type:
- Article
Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson’s disease.
- Published in:
- Journal of Neural Transmission, 2010, v. 117, n. 8, p. 1019, doi. 10.1007/s00702-010-0431-6
- By:
- Publication type:
- Article
Aβ-directed Single-chain Antibody Delivery Via a Serotype-1 AAV Vector Improves Learning Behavior and Pathology in Alzheimer's Disease Mice.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 8, p. 1471, doi. 10.1038/mt.2010.111
- By:
- Publication type:
- Article
Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 28, p. 9567, doi. 10.1523/JNEUROSCI.0942-10.2010
- By:
- Publication type:
- Article
α-Synuclein mediates alterations in membrane conductance: a potential role for α-synuclein oligomers in cell vulnerability.
- Published in:
- European Journal of Neuroscience, 2010, v. 32, n. 1, p. 10, doi. 10.1111/j.1460-9568.2010.07266.x
- By:
- Publication type:
- Article
Generating Differentially Targeted Amyloid-β Specific Intrabodies as a Passive Vaccination Strategy for Alzheimer's Disease.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2031, doi. 10.1038/mt.2009.174
- By:
- Publication type:
- Article
Evolving From Reductionism to Holism.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity.
- Published in:
- Neurotoxicity Research, 2009, v. 16, n. 3, p. 238, doi. 10.1007/s12640-009-9053-x
- By:
- Publication type:
- Article
Nur(R1)turing a Notion on the Etiopathogenesis of Parkinson’s Disease.
- Published in:
- Neurotoxicity Research, 2009, v. 16, n. 3, p. 261, doi. 10.1007/s12640-009-9056-7
- By:
- Publication type:
- Article
HUMMR, a hypoxia-and HIF-1α--inducible protein, alters mitochondrial distribution and transport.
- Published in:
- Journal of Cell Biology, 2009, v. 185, n. 6, p. 1065, doi. 10.1083/jcb.200811033
- By:
- Publication type:
- Article
Identification of a Novel Nurr1-Interacting Protein.
- Published in:
- Journal of Neuroscience, 2008, v. 28, n. 37, p. 9277, doi. 10.1523/JNEUROSCI.3021-08.2008
- By:
- Publication type:
- Article
Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 8, p. 1392, doi. 10.1038/mt.2008.113
- By:
- Publication type:
- Article
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 663, doi. 10.1007/s00262-007-0405-1
- By:
- Publication type:
- Article
Reduced Pathology and Improved Behavioral Performance in Alzheimer's Disease Mice Vaccinated With HSV Amplicons Expressing Amyloid-β and Interleukin-4.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 5, p. 845, doi. 10.1038/mt.2008.39
- By:
- Publication type:
- Article
Sam Seifter Reflections.
- Published in:
- Einstein Journal of Biology & Medicine, 2008, v. 24, n. 1, p. 18
- By:
- Publication type:
- Article
CNS Delivery of Vectored Prion-specific Single-chain Antibodies Delays Disease Onset.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 481, doi. 10.1038/sj.mt.6300387
- By:
- Publication type:
- Article
The Good, the Bad, and the Cell Type-Specific Roles of Hypoxia Inducible Factor-1αin Neurons and Astrocytes.
- Published in:
- Journal of Neuroscience, 2008, v. 28, n. 8, p. 1988, doi. 10.1523/JNEUROSCI.5323-07.2008
- By:
- Publication type:
- Article
Hexamethylene bisacetamide leads to reduced helper virus-free HSV-1 amplicon expression titers via suppression of ICP0.
- Published in:
- Journal of Gene Medicine, 2008, v. 10, n. 2, p. 152, doi. 10.1002/jgm.1130
- By:
- Publication type:
- Article
Neuronal Specificity of HSV/Sleeping Beauty Amplicon Transduction In Utero Is Driven Primarily by Tropism and Cell Type Composition.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 10, p. 1848, doi. 10.1038/sj.mt.6300267
- By:
- Publication type:
- Article